Waddell & Reed Financial’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-900,760
Closed -$94M 588
2017
Q4
$94M Sell
900,760
-1,425,640
-61% -$161M 0.21% 120
2017
Q3
$339M Sell
2,326,400
-85,194
-4% -$11.6M 0.75% 27
2017
Q2
$313M Buy
2,411,594
+54,214
+2% +$6.64M 0.69% 33
2017
Q1
$293M Sell
2,357,380
-32,721
-1% -$3.92M 0.62% 38
2016
Q4
$277M Buy
2,390,101
+539,952
+29% +$60.1M 0.61% 44
2016
Q3
$193M Sell
1,850,149
-1,358,095
-42% -$147M 0.4% 68
2016
Q2
$316M Sell
3,208,244
-1,232,410
-28% -$127M 0.67% 36
2016
Q1
$444M Sell
4,440,654
-487,443
-10% -$50.2M 0.83% 26
2015
Q4
$590M Sell
4,928,097
-94,503
-2% -$10.9M 0.96% 24
2015
Q3
$543M Buy
5,022,600
+312,144
+7% +$38.7M 0.89% 26
2015
Q2
$545M Buy
4,710,456
+744,548
+19% +$85.1M 0.78% 37
2015
Q1
$457M Buy
3,965,908
+1,228,863
+45% +$147M 0.64% 45
2014
Q4
$306M Buy
2,737,045
+46,392
+2% +$4.89M 0.42% 73
2014
Q3
$255M Sell
2,690,653
-126,995
-5% -$11.5M 0.35% 83
2014
Q2
$242M Buy
2,817,648
+67,960
+2% +$5.17M 0.35% 78
2014
Q1
$192M Buy
2,749,688
+312,024
+13% +$24.7M 0.29% 89
2013
Q4
$206M Buy
2,437,664
+794,988
+48% +$62.9M 0.33% 83
2013
Q3
$126M Buy
+1,642,676
New +$115M 0.24% 112

Other funds holding CELG

Waddell & Reed Financial's CELG Position: Q1 2018 in Review

Waddell & Reed Financial sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 900,760 shares — an estimated $94M sold.

Waddell & Reed Financial first reported a position in CELG in Q3 2013 and held it in 18 quarters. The position peaked at $590M in Q4 2015. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Waddell & Reed Financial reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Waddell & Reed Financial sold 900,760 Celgene Corp shares in Q1 2018, an estimated $94M.
  • Waddell & Reed Financial first reported a position in Celgene Corp in Q3 2013 and held it in 18 quarters.
  • Waddell & Reed Financial's Celgene Corp position peaked at $590M in Q4 2015.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Waddell & Reed Financial's 13F filing for Q1 2018, filed 15 May 2018.